Avoro Capital Advisors
Venture capital · New York, New York, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
6Deep-tech portfolio2 active
4Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Relay Therapeutics
55Co-investorsShare a portfolio company
Portfolio · 6 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Disc Medicine | Biotech | Active | — | — |
| Ottimo Pharma | Biotech | Active | — | — |
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Acelyrin | Biotech | Acquired | — | — |
| Hemab Therapeutics | Biotech | Public | — | — |
| ViceBio | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#67
Portfolio exits#49
Raises, 12 months#88
Co-investors#24
Co-investors
- Biotechnology Value FundVenture capital2 shared
- LifeSci Venture PartnersVenture capital2 shared
- Logos CapitalVenture capital2 shared
- MedicxiVenture capital2 shared
- Perceptive AdvisorsVenture capital2 shared
- RA CapitalVenture capital2 shared
- venBio PartnersVenture capital2 shared
- Access BiotechnologyVenture capital1 shared
- Aisling CapitalVenture capital1 shared
- Alexandria Venture InvestmentsVenture capital1 shared
Sectors
- Biotech6
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.